Intrinsic Interventions Inc., VistaFlow (25545)
Specialty: Toxicology / TDM
Welcome to the PulseAid listing for the Intrinsic Interventions Inc., VistaFlow medical device. This device is used in the Toxicology / TDM healthcare specialty. Below, you can view the analytes this device is used to test, and its corresponding complexity (HIGH, MODERATE, or CLIA WAIVED). We have also randomly listed additional medical devices used in the Toxicology / TDM healthcare specialty at the bottom of the page.
Analytes Measured/Detected and Complexity:
| ANALYTE | COMPLEXITY |
| Amphetamines (CR160269 | K122809) | CLIA WAIVED Effective Date: 2016-10-26 |
| Barbiturates (CR160269 | K122809) | CLIA WAIVED Effective Date: 2016-10-26 |
| Benzodiazepines (CR160269 | K122809) | CLIA WAIVED Effective Date: 2016-10-26 |
| Buprenorphine (CR160269 | K122809) | CLIA WAIVED Effective Date: 2016-10-26 |
| Cannabinoids (THC) (CR160269 | K122809) | CLIA WAIVED Effective Date: 2016-10-26 |
| Cocaine metabolites (CR160269 | K122809) | CLIA WAIVED Effective Date: 2016-10-26 |
| Methadone (CR160269 | K122809) | CLIA WAIVED Effective Date: 2016-10-26 |
| Methadone metabolite (EDDP) (CR160269 | K122809) | CLIA WAIVED Effective Date: 2016-10-26 |
| Methamphetamines (CR160269 | K122809) | CLIA WAIVED Effective Date: 2016-10-26 |
| Methylenedioxymethamphetamine (MDMA) (CR160269 | K122809) | CLIA WAIVED Effective Date: 2016-10-26 |
| Morphine (CR160269 | K122809) | CLIA WAIVED Effective Date: 2016-10-26 |
| Opiates (CR160269 | K122809) | CLIA WAIVED Effective Date: 2016-10-26 |
| Oxycodone (CR160269 | K122809) | CLIA WAIVED Effective Date: 2016-10-26 |
| Phencyclidine (PCP) (CR160269 | K122809) | CLIA WAIVED Effective Date: 2016-10-26 |
| Propoxyphene (CR160269 | K122809) | MODERATE Effective Date: 2016-10-26 |
| Tricyclic antidepressants (CR160269 | K122809) | CLIA WAIVED Effective Date: 2016-10-26 |